High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.9M
$1,863,313
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| ACAD |
ACADIA PHARMACEUTICALS INC
|
CFO
Sell to Cover
|
2026-03-26 | $804 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
2026-03-26
$23,750
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
|
2026-03-26 | $23,750 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
2026-03-26
$261
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
|
2026-03-26 | $261 | S | Form 4 |
| ACAD |
ACADIA PHARMACEUTICALS INC
|
CFO
Sell to Cover
|
2026-03-26 | $68,652 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Owen Adams Catherine
• CEO
Sell to CoverΔOwn -44.0%
2026-03-25
$249,932
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
CEO
Sell to CoverΔOwn -44.0%
|
2026-03-25 | $249,932 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Rhodes Jennifer J
• Officer • EVP, CHIEF LEGAL OFFICER, SEC
Sell to CoverΔOwn -25.4%
2026-03-25
$82,531
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • EVP, CHIEF LEGAL OFFICER, SEC
Sell to CoverΔOwn -25.4%
|
2026-03-25 | $82,531 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
2026-03-25
$17,885
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to Cover
|
2026-03-25 | $17,885 | S | Form 4 |
| ACAD |
ACADIA PHARMACEUTICALS INC
|
CFO
Sell to Cover
|
2026-03-25 | $89,680 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Thompson Elizabeth H.Z.
• Officer • EVP, Head of Research & Dev
Sell to CoverΔOwn -51.1%
2026-03-25
$73,749
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • EVP, Head of Research & Dev
Sell to CoverΔOwn -51.1%
|
2026-03-25 | $73,749 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Rhodes Jennifer J
• Officer • EVP, CHIEF LEGAL OFFICER, SEC
Sell to CoverΔOwn -47.7%
2026-02-09
$162,491
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • EVP, CHIEF LEGAL OFFICER, SEC
Sell to CoverΔOwn -47.7%
|
2026-02-09 | $162,491 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Kihara James
• Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to CoverΔOwn -14.0%
2025-11-18
$96,754
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Officer • PRINCIPAL ACCOUNTING OFFICER
Sell to CoverΔOwn -14.0%
|
2025-11-18 | $96,754 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Schneyer Mark C.
• CFO
Sell to CoverΔOwn -16.1%
2025-11-18
$243,114
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
CFO
Sell to CoverΔOwn -16.1%
|
2025-11-18 | $243,114 | S | Form 4 |
|
ACAD
S
ACADIA PHARMACEUTICALS INC
Daly James M
• Director
Discretionary SellΔOwn -88.1%
2025-11-10
$670,983
|
||||||
| ACAD |
ACADIA PHARMACEUTICALS INC
|
Director
Discretionary SellΔOwn -88.1%
|
2025-11-10 | $670,983 | S | Form 4 |
| ACAD |
ACADIA PHARMACEUTICALS INC
|
CFO
Sell to Cover
|
2025-09-15 | $82,728 | S | Form 4 |